NCT04370509 2025-11-19
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
University of California, San Francisco
Phase 2 Terminated
Clinical Trials
1 trialsInterventional × Clear-cell metastatic renal cell carcinoma × Cytoreduction Surgical Procedures × Clear all